Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-11-30Clinical Trial Update: Safety and Efficacy of Vitamin C Infusion in Combination With Local mEHT to Treat Non Small Cell Lung Cancer [Phase 1, Phase 2]
Clinical trial investigating safety and efficacy of high-dose vitamin C infusion with local hyperthermia (mEHT) in various stages of non-sma…
-
CLINICAL_TRIALS trial_result · 2018-11-28Clinical Trial Update: Study of Pemetrexed+Platinum Chemotherapy With or Without Pembrolizumab (MK-3475) in Participants With First Line Metastatic Nonsquamous Non-small Cell Lung Cancer (MK-3475-189/KEYNOTE-189) [Phase 3]
Phase 3 KEYNOTE-189 study evaluating pembrolizumab plus pemetrexed and platinum versus chemotherapy alone in first-line metastatic nonsquamo…
-
CLINICAL_TRIALS trial_result · 2018-11-28Clinical Trial Update: A Study of Anlotinib in Combination With Docetaxel Versus Docetaxel Alone in Participants With Advanced NSCLC [Phase 2]
Phase 2 trial evaluating anlotinib plus docetaxel versus docetaxel alone in advanced non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2018-11-27Clinical Trial Update: Icotinib Combined With Radiation Therapy For NSCLC Patients With Brain Metastases and EGFR Mutation [Phase 2]
Phase 2 trial evaluating icotinib with radiation therapy for non-small cell lung cancer with brain metastases and EGFR mutation.
-
CLINICAL_TRIALS trial_result · 2018-11-26Clinical Trial Update: Anlotinib Combined With Docetaxel for Advanced Non-squamous Non-Small Cell Lung Cancer [Phase 2]
Phase 2 trial evaluating anlotinib in combination with docetaxel for advanced non-squamous non-small cell lung cancer. Status is unknown.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-11-21Clinical Trial Update: Icotinib as Neoadjuvant Therapy in EGFR-mutant Stage ⅢA-N2 Non-small Cell Lung Cancer [Phase 2]
Phase 2 clinical trial evaluating icotinib as neoadjuvant therapy for EGFR-mutant stage IIIA-N2 non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2018-11-21Clinical Trial Update: Hsp90 Inhibitor AUY922 and Erlotinib Hydrochloride in Treating Patients With Stage IIIB-IV Non-Small Cell Lung Cancer [Phase 1, Phase 2]
Clinical trial update on Hsp90 inhibitor AUY922 combined with erlotinib in stage IIIB-IV non-small cell lung cancer; study completed with po…
-
CLINICAL_TRIALS trial_result · 2018-11-14Clinical Trial Update: A Study of Atezolizumab Compared With Gemcitabine Plus (+) Cisplatin or Carboplatin for PD-L1-Selected Participants With Stage IV Squamous Non-Small Cell Lung Cancer (NSCLC) (IMpower111) [Phase 3]
Phase 3 IMpower111 trial comparing atezolizumab to gemcitabine plus cisplatin or carboplatin in PD-L1-selected stage IV squamous non-small c…
-
CLINICAL_TRIALS research · 2018-11-09Clinical Trial Update: Study of Patient Preference for Oral or Intravenous Vinorelbine in the Treatment of Advanced NSCLC [Phase 4]
A Phase 4 trial evaluating patient preference for oral versus intravenous vinorelbine in metastatic non-small cell lung cancer has completed…
-
CLINICAL_TRIALS trial_result · 2018-11-08Clinical Trial Update: Anlotinib Combined With Docetaxel for Advanced Non-Small Cell Lung Cancer（ALTER-L034） [Phase 2]
A Phase 2 clinical trial updating on Anlotinib combined with Docetaxel for advanced non-small cell lung cancer (ALTER-L034).
-
CLINICAL_TRIALS trial_result · 2018-11-07Clinical Trial Update: Avastin and Tarceva for Locally Advanced or Metastatic Non-Squamous Non-Small-Cell Lung Cancer [Phase 1, Phase 2]
Clinical trial update involving Avastin and Tarceva for locally advanced or metastatic non-squamous non-small cell lung cancer across Phase …
-
CLINICAL_TRIALS trial_result · 2018-11-07Clinical Trial Update: Bevacizumab in the Treatment of Malignant Pleural Effusions of Non-squamous Non-small Cell Lung Cancer [Phase 2]
Phase 2 trial update evaluating bevacizumab for malignant pleural effusions in patients with non-squamous non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2018-11-06Clinical Trial Update: AZD9291 Versus Gefitinib or Erlotinib in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer [Phase 3]
Phase 3 trial comparing AZD9291 (osimertinib) to gefitinib or erlotinib in locally advanced or metastatic EGFR-sensitizing mutation positive…
-
FDA approval · 2018-11-02FDA Approved: LORBRENA — Original Application (Pfizer Laboratories Div Pfizer Inc)
FDA approved Lorlatinib (LORBRENA) as the original application for treatment of ALK-positive metastatic non-small cell lung cancer in adults…
-
CLINICAL_TRIALS trial_result · 2018-11-02Clinical Trial Update: Anlotinib Hydrochloride as Second-line Therapy in Elderly Patients With EGFR Wild-type Lung Adenocarcinoma [Phase 2]
Phase 2 trial update evaluating Anlotinib for second-line therapy in elderly patients with EGFR wild-type lung adenocarcinoma.
-
CLINICAL_TRIALS trial_result · 2018-10-26Clinical Trial Update: ARCHER1050: A Study of Dacomitinib vs. Gefitinib in 1st-Line Treatment Of Advanced NSCLC. [Phase 3]
Phase 3 trial comparing dacomitinib to gefitinib in first-line advanced non-small cell lung cancer with EGFR-activating mutations; results p…
-
CLINICAL_TRIALS trial_result · 2018-10-26Clinical Trial Update: A Study of Erlotinib in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor Mutations [Phase 2]
Phase 2 trial evaluating erlotinib in locally advanced or metastatic non-small cell lung cancer with EGFR mutations has completed with resul…
-
CLINICAL_TRIALS trial_result · 2018-10-26Clinical Trial Update: Cisplatin and Gemcitabine Plus Trastuzumab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer [Phase 2]
Phase 2 trial evaluating cisplatin and gemcitabine with trastuzumab in stage IIIB/IV non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2018-10-26Clinical Trial Update: Parp Inhibitor in Advanced Non-Small Cell Lung Cancer (PIN) [Phase 2]
Phase 2 clinical trial update for a PARP inhibitor in advanced non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2018-10-25Clinical Trial Update: EGFR-TKIs Combine With Anlotinib as First-line Treatment for Patients With Advanced EGFR Mutation-positive NSCLC [Phase 2]
Phase 2 trial exploring a combination of EGFR-TKIs with anlotinib as first-line therapy for advanced EGFR mutation-positive non-small cell l…
-
CLINICAL_TRIALS trial_result · 2018-10-19Clinical Trial Update: Study of LY573636-Sodium in Patients With Metastatic Non-Small Cell Lung Cancer [Phase 2]
Phase 2 trial update for LY573636-Sodium in patients with metastatic non-small cell lung cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2018-10-16Clinical Trial Update: Sunitinib Non Small Cell Lung Cancer Patients Over 70 [Phase 2]
Phase 2 trial update of sunitinib in non-small cell lung cancer patients over 70 completed with results posted.
-
CLINICAL_TRIALS trial_result · 2018-10-15Clinical Trial Update: A Study of VAL401 in the Treatment of Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer [Phase 2]
Phase 2 clinical trial of VAL401 in locally advanced or metastatic non-small cell lung cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2018-10-12Clinical Trial Update: Anlotinib Versus Docetaxel as the Second-line Treatment in EGFR Wild Type Patients With Advanced NSCLC [Phase 2]
Phase 2 trial comparing anlotinib to docetaxel as second-line therapy in EGFR wild-type advanced non-small cell lung cancer; status of the t…
-
CLINICAL_TRIALS trial_result · 2018-10-12Clinical Trial Update: Pharmacokinetic & Pharmacodynamic Study of ABT-751 With Carboplatin in Patients With Advanced Lung Cancer [Phase 1, Phase 2]
Phase 1/2 trial update of ABT-751 with carboplatin in advanced lung cancer has been terminated; results posted in 2018.